Karen L. Zaderej - 27 Dec 2022 Form 4 Insider Report for Axogen, Inc. (AXGN)

Role: CEO, Director
Signature: /s/ Karen Zaderej
Issuer symbol: AXGN
Transactions as of: 27 Dec 2022
Net transactions value: $0
Form type: 4
Filing time: 29 Dec 2022, 19:35:33 UTC
Previous filing: 16 Dec 2022
Next filing: 20 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AXGN	Common Stock	Options Exercise	$0	+4,400	+0.44%	$0.000000	1,012,695	27 Dec 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AXGN	Restricted Stock Units	Options Exercise	$0	+4,400		$0.000000^*	0	27 Dec 2022	Common Stock	4,400		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This reflects the number of restricted stock units that vested on December 27, 2022.
F2	Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
F3	All shares of AxoGen Inc. common stock underlying the restricted stock units vested on December 27, 2022 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 27, 2020 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter.